NCT05446259 Degenerative Cervical Myelopathy Repository
| NCT ID | NCT05446259 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Francis Farhadi |
| Condition | Cervical Myelopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 245 participants |
| Start Date | 2022-07-13 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 245 participants in total. It began in 2022-07-13 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To create a research repository of patients with known degenerative cervical myelopathy (DCM) and a control cohort of subjects who have non-myelopathic spinal disease. This repository will be used to assess functional and/or biological measures that may allow for improved prediction of symptomatic progression and response to treatment in patients with DCM. In addition, this repository will be used to develop a risk assessment scale to accurately predict functional outcomes following operative management of DCM.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of degenerative cervical myelopathy * Diagnosis of cervical degenerative disease without myelopathy Exclusion Criteria: * None outside or diagnostic requirements and age limits.
Contact & Investigator
Francis Farhadi, MD, PhD
PRINCIPAL INVESTIGATOR
University of Kentucky
Frequently Asked Questions
Who can join the NCT05446259 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Cervical Myelopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05446259 currently recruiting?
Yes, NCT05446259 is actively recruiting participants. Contact the research team at francis.farhadi@uky.edu for enrollment information.
Where is the NCT05446259 trial being conducted?
This trial is being conducted at Lexington, United States.
Who is sponsoring the NCT05446259 clinical trial?
NCT05446259 is sponsored by Francis Farhadi. The principal investigator is Francis Farhadi, MD, PhD at University of Kentucky. The trial plans to enroll 245 participants.